JZP-258
JZP080-301
Phase 3 small_molecule completed
Quick answer
JZP-258 for Idiopathic Hypersomnia is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Idiopathic Hypersomnia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed